Global Biosimilar Market 2017- Astra Zeneca Plc, Amgen Inc and Biocon Ltd
The valuation of Global Biosimilar Market is USD 3 billion in 2016. The Biosimilar market is estimated to reach USD 58.40 billion in 2022, growing at a CAGR of 52.77% between 2016 and 2022 according to this study.
View full press release